Keyphrases
Dexmedetomidine
40%
Pharmacokinetic Model
29%
Target-controlled Infusion
26%
Drug Interactions
25%
Anesthetic Drugs
24%
Dose Titration
22%
Bispectral Index
18%
Interaction Model
14%
Pharmacodynamics
13%
Noxious Stimuli
13%
Clinical Practice
13%
Surgical Pleth Index
12%
General Anesthesia
11%
Tolerance Response
11%
Propofol
11%
Interaction Modeling
11%
Clinical Validation
11%
Healthy Volunteers
11%
Multidrug
11%
Percutaneous Endoscopic Gastrostomy
11%
Population-based Modeling
11%
Surfing
11%
Pharmacokinetic-pharmacodynamic Modeling
11%
Drug Pharmacokinetics
11%
Gastric Volvulus
11%
Cardiac Arrest
11%
Infusion Model
11%
Drug Exposure
11%
Dosing Regimen
11%
Prospective Observational Trial
11%
Two-center
11%
Linear Pharmacokinetics
11%
Postoperative Outcomes
11%
Plasma Concentration
10%
Anesthesia
9%
Response Index
9%
Stimuli-responsiveness
9%
Target Concentration
8%
Pharmacokinetics
8%
Sedation
8%
Sevoflurane
7%
Remifentanil
7%
StO2
6%
Body Mass Index
6%
Mathematical Model
5%
Allometric Models
5%
Blood Pressure
5%
Blood Circulation
5%
Mediastinal Shift
5%
Advanced Life Support
5%
Medicine and Dentistry
Bispectral Index
62%
Remifentanil
48%
Propofol
48%
Pharmacodynamics
39%
Sevoflurane
34%
Pharmacokinetics
26%
General Anesthesia
25%
Laryngoscopy
25%
Hemodynamic
24%
Nociceptive Stimulation
24%
Target-Controlled Infusion
14%
Observational Study
13%
Anesthetic Agent
13%
K-Complex
13%
Drug Interaction
12%
Stomach Volvulus
11%
Heart Arrest
11%
Gastrostomy
11%
Titrimetry
11%
Dexmedetomidine
11%
Volunteer
11%
Analgesic Activity
11%
Balanced Anesthesia
11%
Noradrenalin
8%
Drug Effect
7%
Anesthesiologist
5%
Hiatus Hernia
5%
Advanced Life Support
5%
Mean Arterial Pressure
5%
Basic Life Support
5%
Resuscitation
5%
Venous Return
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Pharmacodynamics
89%
Dexmedetomidine
66%
Propofol
48%
Anesthetic Agent
42%
Normal Human
36%
Remifentanil
25%
Drug Interaction
15%
Clinical Pharmacokinetics
11%
Sevoflurane
11%
Hypotension
9%
Drug Administration
8%
Side Effect
8%
NONMEM
7%
Observational Study
5%
PK/PD Models
5%